Literature DB >> 7358865

The measurement of pharmaceutical innovation.

W M Wardell, J DiRaddo.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7358865     DOI: 10.1002/j.1552-4604.1980.tb01660.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  5 in total

1.  Novel medicines marketed in the UK (1960-87).

Authors:  Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

2.  The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications.

Authors:  Ernst R Berndt; Iain M Cockburn; Karen A Grépin
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

3.  Trends in the development of new medicines by UK-owned pharmaceutical companies (1964-1980).

Authors:  R A Prentis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

4.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

Authors:  R A Prentis; Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Toward a definition of pharmaceutical innovation.

Authors:  Steven Morgan; Ruth Lopert; Devon Greyson
Journal:  Open Med       Date:  2008-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.